Halozyme Therapeutics Inc. (HALO) |
|
16.96 0.05 (0.3%)
|
07-16 16:00 |
|
Open: |
16.89 |
Pre. Close: |
16.91 |
|
High:
|
17.14 |
Low:
|
16.86 |
|
Volume:
|
631,110 |
Market Cap:
|
2468M |
|
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
17.048 - 17.151 |
17.151 - 17.25 |
|
Low:
|
16.348 - 16.469 |
16.469 - 16.584 |
|
Close:
|
16.724 - 16.903 |
16.903 - 17.074 |
|
Technical analysis |
as of: 2019-07-16 3:21:19 PM |
|
Overall:
|
  |
| Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 20.78 One year: 24.27 |
| Support: |
Support1: 16.18 Support2: 15.19 |
| Resistance: |
Resistance1: 17.79 Resistance2: 20.78 |
| Pivot: |
17.02 |
| Moving Average: |
MA(5): 16.88  MA(20): 16.87
MA(100): 16.32 MA(250): 16.45 |
| MACD: |
MACD(12,26): 0.26 Signal(9): 0.32 |
| Stochastic oscillator: |
%K(14,3): 45.36 %D(3): 43.97 |
| RSI: |
RSI(14): 55.47 |
| 52-week: |
High: 18.85 Low: 13.24 Change(%): -2.2 |
| Average Vol(K): |
3-Month: 87484 10-Days: 74020 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.HALO has closed above bottom band by 48.2%. Bollinger Bands are 10.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Wed, 03 Jul 2019 13:38:01 Z
JKK's Holdings Imply 14% Gain Potential
Wed, 26 Jun 2019 17:12:13 Z
Interesting HALO Put And Call Options For August 16th
Mon, 17 Jun 2019 17:29:33 Z
HALO Makes Bullish Cross Above Critical Moving Average
Wed, 12 Jun 2019 21:07:57 Z
Notable Wednesday Option Activity: HALO, JNJ, C
Tue, 21 May 2019 14:16:20 Z
Alexion (ALXN) Stock Up 30.7% YTD: Will the Momentum Stay?
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
|
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
 |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
145.51 |
| Shares Float (M) |
132.82 |
|
% Held by Insiders
|
8.48 |
|
% Held by Institutions
|
|
|
Shares Short (K)
|
7580 |
|
Shares Short P. Month (K)
|
|
Stock Financials |
|
EPS
|
-0.360 |
|
EPS Est. Current Year
|
-0.130 |
|
EPS Est. Next Year
|
-0.790 |
|
EPS Est. Next Quarter
|
0.270 |
|
Forward EPS
|
-0.560 |
|
Book Value (p.s.)
|
1.800 |
|
PEG Ratio
|
-0.75 |
|
Profit Margin
|
-28.70 |
|
Operating Margin
|
-23.97 |
|
Return on Assets (ttm)
|
-5.8 |
|
Return on Equity (ttm)
|
-19.5 |
|
Qtrly Rev. Growth
|
84.5 |
|
Gross Profit (p.s.)
|
-0.059 |
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
-0.277 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-31.75 |
|
Levered Free Cash Flow (M)
|
-18.48 |
Stock Valuations |
|
P/E
|
-47.21 |
|
P/E Growth Ratio
|
0.01 |
|
P/BV
|
9.44 |
|
P/S
|
1994308480.00 |
|
P/CF
|
-77.89 |
Dividends & Splits |
|
Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Forward Dividend
|
|
|
Last Split Date
|
|
|
Last Split Ratio
|
-1e+010 |
|
7 Binary Options
|
|
Your Ad Here
|
|
